This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
Ultrasound screening was compared with no screening (incidental detection). It was assumed that only one scan was performed if no aneurysm was detected.
Location/setting
Italy/secondary care.
Methods

Analytical approach:
The analysis was based on a Markov model, with a lifetime horizon. The authors stated that it was conducted from the perspective of the Italian NHS.
Effectiveness data:
The clinical data were from selected sources and authors' opinions. Most of the evidence was from randomised controlled trials (RCTs) identified by a recent Cochrane review or from a UK Health Technology Assessment (HTA). The patients' characteristics and other local data were from a pilot programme, at an Italian hospital (San Martino Hospital, Genova), with 4,327 individuals attending for screening. Other data were from national databases. The transition rates and mortality due to ruptured aneurysms were key inputs. Some assumptions were made and justified.
Monetary benefit and utility valuations:
The utility values for the health states were from the Italian pilot programme study.
Measure of benefit:
Quality-adjusted life-years (QALYs) and life-years were the summary benefit measures and they were discounted at an annual rate of 3%.
Cost data:
The economic analysis included the costs of invitation to screening, ultrasound examination, emergency aneurysm treatment (including endovascular aneurysm repair and open surgery), and follow-up (visits, abdominal computed tomography, and ultrasound). All costs for screening implementation were from the Italian pilot programme study, while those for follow-up were from regional out-patient procedure tariffs. All costs were presented in Euros (EUR) and US dollars ($) and were discounted at an annual rate of 3%.
